Meruvax Pharma LLC - TX Dallas, Dallas 75220

Meruvax Pharma LLC entered the industry of Commercial Medical Research in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Mohan Goli by calling (469) 531-5810 during business hours. You can also write to the business’ Single Location at 9982 Monroe Drive # 402, Dallas, Texas TX 75220. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Meruvax Pharma LLC
Representative: Mohan Goli
Place of Business: 9982 Monroe Drive # 402, Dallas, TX 75220
Contact Number: (469) 531-5810
Type of Service: Commercial Medical Research
SIC Number: 8731
NAICS Number: 541712
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2011
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Meruvax Pharma LLC is a company operating from Dallas, Texas providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2011 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.

With a current employee count of 1 to 4, Meruvax Pharma LLC has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Mohan Goli at (469) 531-5810 for related queries, or to locate its Single Location using the coordinates 32.880254,-96.878141.

The Single Location can also be found at the street address 9982 Monroe Drive # 402 in Dallas, Texas 75220 and can be engaged online through the company website at , the company Twitter , and Facebook page .